TY - JOUR
T1 - Endovascular treatment of chronic splanchnic syndrome
AU - van Wanroij, J. L.
AU - van Petersen, A. S.
AU - Huisman, A. B.
AU - Mensink, P. B F
AU - Gerrits, D. G.
AU - Kolkman, J. J.
AU - Geelkerken, R. H.
PY - 2004/8/1
Y1 - 2004/8/1
N2 - Objective. The technical and clinical outcome of endovascular revascularization was analyzed in patients with suspicion of chronic splanchnic syndrome (CSS). Methods. Medical history, duplex, angiography and exercise gastric tonometry suggested CSS in 97 patients. Twenty-seven of them were treated endovascular (one patient had 3-vessel, 12 patients had 2-vessels, 14 patients had 1-vessel CSS). Five patients received previous splanchnic revascularization. Twenty-three patients (85%) had severe co-morbidity: cardiac, pulmonary or cachexia. Endovascular treatment consisted of percutaneous transluminal angiography (PTA) of the coeliac artery (CA) or superior mesenteric artery (SMA) in three and primary balloon expandable stenting in 24 patients (13 CA and 10 SMA solitary, two CA and SMA both, 31 splanchnic arteries in total). Results. Three patients showed procedure related complications (11%). Mean follow-up was 19, range 2-76 months. Two patients died during follow up, both not procedure or CSS related. Five patients had no improvement of symptoms, without evidence of re- or residual stenosis. The primary clinical success was 67%, secondary clinical success was 81%. The primary patency was 81% and secondary patency was 100%. Conclusion. Endovascular treatment of CSS has a reasonable outcome. It is an alternative to operative treatment, especially in patients with high co-morbidity or limited life expectancy.
AB - Objective. The technical and clinical outcome of endovascular revascularization was analyzed in patients with suspicion of chronic splanchnic syndrome (CSS). Methods. Medical history, duplex, angiography and exercise gastric tonometry suggested CSS in 97 patients. Twenty-seven of them were treated endovascular (one patient had 3-vessel, 12 patients had 2-vessels, 14 patients had 1-vessel CSS). Five patients received previous splanchnic revascularization. Twenty-three patients (85%) had severe co-morbidity: cardiac, pulmonary or cachexia. Endovascular treatment consisted of percutaneous transluminal angiography (PTA) of the coeliac artery (CA) or superior mesenteric artery (SMA) in three and primary balloon expandable stenting in 24 patients (13 CA and 10 SMA solitary, two CA and SMA both, 31 splanchnic arteries in total). Results. Three patients showed procedure related complications (11%). Mean follow-up was 19, range 2-76 months. Two patients died during follow up, both not procedure or CSS related. Five patients had no improvement of symptoms, without evidence of re- or residual stenosis. The primary clinical success was 67%, secondary clinical success was 81%. The primary patency was 81% and secondary patency was 100%. Conclusion. Endovascular treatment of CSS has a reasonable outcome. It is an alternative to operative treatment, especially in patients with high co-morbidity or limited life expectancy.
KW - Atherosclerosis
KW - Balloon expandable stent
KW - Chronic splanchnic syndrome
KW - Endovascular treatment
KW - Mesenteric ischemia
UR - http://www.scopus.com/inward/record.url?scp=3242810565&partnerID=8YFLogxK
U2 - 10.1016/j.ejvs.2004.04.005
DO - 10.1016/j.ejvs.2004.04.005
M3 - Article
C2 - 15234701
AN - SCOPUS:3242810565
SN - 1078-5884
VL - 28
SP - 193
EP - 200
JO - European journal of vascular and endovascular surgery
JF - European journal of vascular and endovascular surgery
IS - 2
ER -
